BSECompany Update6 Oct 2026 · 6 Oct 2026, 06:55 pm

Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Thyrocare Technologies Ltd · 539871

✦ AI SummaryResults

Thyrocare Technologies Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, confirming that the entire holding of the company's shares are in demat form and no requests for rematerialisation were received during the quarter.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Thyrocare Technologies Ltd - 539871 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

408bf38f-9647-4ced-be69-47da72e43fa8.pdf

pdf

Download →
View document text
0 Thyrocare Tests you can trust October 06, 2026 National Stock Exchange of India Limited BSE Ltd. Exchange Plaza Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400051 Mumbai- 400 001 (SYMBOL: THYROCARE) (SCRIP CODE: 539871) Sub: Intimation under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2026 Dear Sir/Madam Pursuant to regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the Certificate for the Quarter ended September 30, 2026, duly certified by Registrar and Share Transfer Agent confirming the requirements. You are requested to kindly take the same on record. Yours faithfully For Thyrocare Technologies Limited Brijesh Kumar Company Secretary and Compliance Officer Encl: A/a Thyrocare Technologies Limited 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400 703, India (9 022-3090 0000 i.':'ii info@thyrocare.com (@ www.thyrocare.com (CIN : L86905MH2000PLC123882) @ MUFG MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400 083 Phone: +91 22 4918 6000 Website: in.mpms.mufg.com To, Date: 06-10-2026 The Compliance Officer/ Company Secretary THYROCARE TECHNOLOGIES LIMITED D/37-1, TTC INDUSTRIAL AREA MIDC TURBHE NAVI MUMBAI - 400703 MAHARASHTRA Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30th, 2026. Dear Sir/Madam, With reference to the captioned regulation, we hereby confirm that the said Regulation is not applicable to the Company, as the entire holding of the Company’s shares are in demat form, and we have not received any request from any members of the Company for rematerialisation during the quarter ended on September 30th, 2026. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry